These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 29234238)
1. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling. Chen G; Wang D; Zhao X; Cao J; Zhao Y; Wang F; Bai J; Luo D; Li L Cancer Cell Int; 2017; 17():118. PubMed ID: 29234238 [TBL] [Abstract][Full Text] [Related]
2. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer. Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793 [TBL] [Abstract][Full Text] [Related]
3. microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1). Li Y; Fu Y; Gao Y; Li H; Ma L; Shu C; Li N; Ma C Int J Clin Exp Pathol; 2018; 11(9):4319-4330. PubMed ID: 31949828 [TBL] [Abstract][Full Text] [Related]
4. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination. Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215 [No Abstract] [Full Text] [Related]
5. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 Liu J; Chen Z; Xiang J; Gu X Oncol Lett; 2018 Apr; 15(4):5561-5568. PubMed ID: 29556299 [TBL] [Abstract][Full Text] [Related]
6. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018 [TBL] [Abstract][Full Text] [Related]
7. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway. Wei RJ; Zhang CH; Yang WZ Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417 [TBL] [Abstract][Full Text] [Related]
8. Zheng Y; Luo M; Lü M; Zhou T; Liu F; Guo X; Zhang J; Kang M Onco Targets Ther; 2020; 13():11193-11209. PubMed ID: 33173311 [TBL] [Abstract][Full Text] [Related]
9. Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway. Lu Q; Zhu J; Teng L; Chen C; Bi L; Chen W Phytomedicine; 2024 Dec; 135():156126. PubMed ID: 39427522 [TBL] [Abstract][Full Text] [Related]
10. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma. Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway. Cheng Y; Qiu L; He GL; Cai L; Peng BJ; Cao YL; Pan MX Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8823-8832. PubMed ID: 31696469 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis. Yu Y; Bian L; Liu R; Wang Y; Xiao X Cancer Cell Int; 2021 Jan; 21(1):10. PubMed ID: 33407443 [TBL] [Abstract][Full Text] [Related]
14. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway. Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
16. CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway. Yang L; Tan W; Wei Y; Xie Z; Li W; Ma X; Wang Q; Li H; Zhang Z; Shang C; Chen Y Cell Death Dis; 2022 May; 13(5):464. PubMed ID: 35581180 [TBL] [Abstract][Full Text] [Related]
17. MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF. Huge N; Reinkens T; Buurman R; Sandbothe M; Bergmann A; Wallaschek H; Vajen B; Stalke A; Decker M; Eilers M; Schäffer V; Dittrich-Breiholz O; Gürlevik E; Kühnel F; Schlegelberger B; Illig T; Skawran B Cancer Cell Int; 2022 May; 22(1):192. PubMed ID: 35578240 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X; Zhang P; Pan Y; Liu Y Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [TBL] [Abstract][Full Text] [Related]
19. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Cao F; Yin LX Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797 [TBL] [Abstract][Full Text] [Related]
20. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis. Zhao JA; Nie W; Dong L; Liu W; Wei W J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]